Immunochromatographic Assay Evaluated for Trichomoniasis
|
By LabMedica International staff writers Posted on 09 Jul 2012 |

Image: The OSOM Trichomonas Rapid Test (Photo courtesy of Sekisui Diagnostics).
The performance of a rapid immunochromatographic assay in the detection and diagnosis of Trichomoniasis vaginalis has been evaluated.
A qualitative antigen-detection immunochromatographic (IC) assay has been compared with other conventional methods in the diagnosis of vaginal trichomoniasis that accounts for nearly half of all curable sexually transmitted diseases worldwide with serious health consequence.
Scientists at the Mansoura University, (Egypt) enrolled 258 females aged 18 to 50 years who were classified into two groups, with 185 symptomatic and 73 as asymptomatic. Vaginal swab specimens were obtained for wet mount, stained preparation with Giemsa and acridine-orange, two different culture media, and for rapid IC testing. The qualitative OSOM Trichomonas Rapid Test uses color immunochromatographic capillary flow dipstick technology to detect the presence of T. vaginalis antigens from vaginal swab samples.
The prevalence of T. vaginalis in the enrollees was 38.37% (99 of 258) by the composite reference standard (CRS) of wet mount microscopy and culture. With the OSOM rapid test (Sekisui Diagnostics, Framingham, MA, USA) T. vaginalis was detected in 37.6% of the enrolled women. By culture, the flagellate was detected in 99 females cultured onto modified Diamond's and in 96 women cultured in InPouch TV media (BioMed Diagnostics, San Jose, CA, USA). There was no significant difference between the results of the OSOM rapid test and those of the culture method, but there were significant difference between the results of the OSOM rapid test and those of mount microscopy.
The authors concluded that the OSOM Trichomonas Rapid Test is an objective point-of-care-test assay that eliminates the human subjective factors in conventional wet microscopy and culture techniques, and is expected to contribute significantly in the diagnosis of vaginal trichomoniasis. The results are available within 10 minutes and it does not require sophisticated equipment. It can be performed on-site by laboratory personnel, nurses, and medical practitioners with minimal training. In addition, numerous samples can be screened at the same time. The antigen-detection test is useful in settings where a rapid point-of-care test is needed and where microscopy and culture are impractical, and in outpatient clinics where there is a rapid turnaround of patients. The study was published on June 21, 2012, in the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Mansoura University
Sekisui Diagnostics
A qualitative antigen-detection immunochromatographic (IC) assay has been compared with other conventional methods in the diagnosis of vaginal trichomoniasis that accounts for nearly half of all curable sexually transmitted diseases worldwide with serious health consequence.
Scientists at the Mansoura University, (Egypt) enrolled 258 females aged 18 to 50 years who were classified into two groups, with 185 symptomatic and 73 as asymptomatic. Vaginal swab specimens were obtained for wet mount, stained preparation with Giemsa and acridine-orange, two different culture media, and for rapid IC testing. The qualitative OSOM Trichomonas Rapid Test uses color immunochromatographic capillary flow dipstick technology to detect the presence of T. vaginalis antigens from vaginal swab samples.
The prevalence of T. vaginalis in the enrollees was 38.37% (99 of 258) by the composite reference standard (CRS) of wet mount microscopy and culture. With the OSOM rapid test (Sekisui Diagnostics, Framingham, MA, USA) T. vaginalis was detected in 37.6% of the enrolled women. By culture, the flagellate was detected in 99 females cultured onto modified Diamond's and in 96 women cultured in InPouch TV media (BioMed Diagnostics, San Jose, CA, USA). There was no significant difference between the results of the OSOM rapid test and those of the culture method, but there were significant difference between the results of the OSOM rapid test and those of mount microscopy.
The authors concluded that the OSOM Trichomonas Rapid Test is an objective point-of-care-test assay that eliminates the human subjective factors in conventional wet microscopy and culture techniques, and is expected to contribute significantly in the diagnosis of vaginal trichomoniasis. The results are available within 10 minutes and it does not require sophisticated equipment. It can be performed on-site by laboratory personnel, nurses, and medical practitioners with minimal training. In addition, numerous samples can be screened at the same time. The antigen-detection test is useful in settings where a rapid point-of-care test is needed and where microscopy and culture are impractical, and in outpatient clinics where there is a rapid turnaround of patients. The study was published on June 21, 2012, in the journal Diagnostic Microbiology and Infectious Disease.
Related Links:
Mansoura University
Sekisui Diagnostics
Latest Microbiology News
- TORCH Infection Trends Point to Need for Tailored Screening in Pregnancy
- Automated Blood Culture System Speeds Detection of Bloodstream Infections
- New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
- Gut Microbiome Signatures Help Identify Risk of IBD Progression
- FDA-Cleared Gastrointestinal Panel Detects 24 Pathogen Targets
- New AMR Assay Supports Rapid Infection Control Screening in Hospitals
- Diagnostic Gaps Complicate Bundibugyo Ebola Outbreak Response in Congo
- Study Finds Hidden Mpox Infections May Drive Ongoing Spread
- Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals
- Molecular Urine and Stool Tests Do Not Improve Early TB Treatment in Hospitalized HIV Patients
- Rapid Antigen Biosensor Detects Active Tuberculosis in One Hour
- Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria
- Oral–Gut Microbiome Signatures Identify Early Gastric Cancer
- Gut Microbiome Test Predicts Melanoma Recurrence After Surgery
- Rapid Blood-Culture Susceptibility Panel Expands Coverage for Gram-Negative Infections
- Antibiotic Resistance Genes Found in Newborns Within Hours of Birth
Channels
Clinical Chemistry
view channel
Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features
Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more
Plasma Vitamin C Levels Associated with Brain Structure and Connectivity in Aging
Previous studies have linked vitamin C–rich diets with lower risk of cognitive impairment in older adults. However, few investigations have directly examined blood plasma vitamin C in relation to brain... Read more
Mass Spectrometry Detects Tumor Metabolites for Cancer Monitoring
Cancer’s altered metabolism complicates how clinicians detect and monitor tumors, because nutrient use can shift with context and time. Measuring small-molecule metabolites that distinguish malignant from... Read more
Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
Many patients with type 2 diabetes and chronic kidney disease continue to experience progressive renal decline, yet conventional markers such as albuminuria and estimated glomerular filtration rate (eGFR)... Read moreMolecular Diagnostics
view channel
Ultrasensitive HPV Blood Test Predicts Early Recurrence in Head and Neck Cancer
Human papillomavirus (HPV)-associated head and neck cancers are frequently treated with surgery, but some patients experience recurrence due to residual microscopic disease. Postoperative decisions about... Read more
New Library Normalization and Amplification Tools Support Oncology Sequencing
High-throughput next-generation sequencing (NGS) laboratories continue to grapple with uneven library pooling and amplification artifacts that can degrade variant calling accuracy and increase reruns.... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read morePathology
view channel
Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer
Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
AI Tool Speeds Brain Tumor Classification from Routine Histology Slides
Accurate classification of brain and spinal cord tumors increasingly depends on molecular profiling alongside histology, but access to such testing remains limited and results can take about two weeks.... Read more
IHC Companion Diagnostic Standardizes Mismatch Repair Testing for Cancer Immunotherapy
Deficient DNA mismatch repair is an established predictive biomarker for response to immune checkpoint inhibitors, yet access to standardized assessment has varied across tumor types. Cancer remains the... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Open-Source Consortium Aims to Standardize Digital Pathology Workflows
Digital pathology is expanding rapidly as laboratories adopt whole-slide imaging and computational tools to meet growing diagnostic and biomarker-testing demand. However, fragmented software infrastructure... Read more




.jpg)



